Related Experiment Video
Updated: Aug 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y)
Marco Ferrone1, Federica Perrone, Elena Tamborini
1Molecular Simulation Engineering Laboratory, Department of Chemical Engineering, University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy.
Abstract:
In human tumors, p53 is often disabled by mutations in its DNA-binding domain and is thus inactive as a transcription factor. Alternatively, MDM2 gene amplification or up-regulation represents a mechanism of p53 wild-type inactivation, mainly reported in soft tissue sarcomas. In a previous TP53 analysis carried out on sporadic and NF1-related malignant peripheral nerve sheath tumors, in two cases, we observed the occurrence of C238Y missense mutation, leading to p53 stabilization unexpectedly coupled with immunophenotypic MDM2 overexpression. To investigate this TP53 missense mutation not yet functionally characterized in mammalian cell, we did MDM2 Southern blot and p53(C238Y)/MDM2 biochemical and functional analyses followed by molecular modeling. The results showed a lack of MDM2 gene amplification, evidence of p53-MDM2 protein complexes, and presence of a p53 that retains the ability to become phosphorylated on Ser15 and to induce the transcription of p21(waf1). Additional molecular modeling data highlighted the structural similarities between p53(C238Y) and wild-type p53, further supporting that the p53(C238Y) mutant still retains functional wild-type p53 properties.
Insights
The TP53 C238Y mutation stabilizes p53 protein without inactivating its function. This specific mutation retains wild-type p53 properties, offering new insights into tumor suppressor activity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- p53 tumor suppressor is often inactivated in human cancers through mutations or MDM2 overexpression.
- MDM2 amplification is a known mechanism for wild-type p53 inactivation, particularly in soft tissue sarcomas.
- A novel TP53 C238Y missense mutation was previously observed in malignant peripheral nerve sheath tumors, paradoxically stabilizing p53 alongside MDM2 overexpression.
Purpose of the Study:
- To functionally characterize the TP53 C238Y missense mutation in mammalian cells.
- To investigate the interaction between the p53 C238Y mutant and MDM2.
- To determine if the p53 C238Y mutant retains wild-type p53 transcriptional activity.
Main Methods:
- MDM2 Southern blot analysis.
- Biochemical and functional assays of p53(C238Y) and MDM2.
- Molecular modeling of the p53 C238Y mutant.
Main Results:
- No evidence of MDM2 gene amplification was found.
- p53-MDM2 protein complexes were detected.
- The p53 C238Y mutant showed phosphorylation on Ser15 and induced p21(waf1) transcription.
- Molecular modeling indicated structural similarities between p53(C238Y) and wild-type p53.
Conclusions:
- The TP53 C238Y mutation does not lead to MDM2 gene amplification.
- The p53 C238Y mutant retains key functional properties of wild-type p53, including transcriptional activity.
- This mutation represents a distinct mechanism of p53 regulation, preserving its tumor-suppressive functions.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

